FYI - For Your Innovation cover image

$7 Trillion For Chips and Drug Pricing | The Brainstorm EP 35

FYI - For Your Innovation

CHAPTER

Viability of Mark Cuban's Generics Company

This chapter dives into the analysis of Mark Cuban's company, Cost Plus Drugs, which specializes in generics. It explores the profitability of this business model, highlighting the significance of manufacturing capabilities, drug production costs, and the future landscape of the industry.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner